Annual SG&A:
$43.46M+$9.97M(+29.77%)Summary
- As of today, PTGX annual SG&A is $43.46 million, with the most recent change of +$9.97 million (+29.77%) on December 31, 2024.
- During the last 3 years, PTGX annual SG&A has risen by +$16.27 million (+59.81%).
- PTGX annual SG&A is now at all-time high.
Performance
PTGX SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$11.13M+$579.00K(+5.49%)Summary
- As of today, PTGX quarterly SG&A is $11.13 million, with the most recent change of +$579.00 thousand (+5.49%) on September 30, 2025.
- Over the past year, PTGX quarterly SG&A has increased by +$972.00 thousand (+9.57%).
- PTGX quarterly SG&A is now -25.35% below its all-time high of $14.91 million, reached on March 31, 2024.
Performance
PTGX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$1.51B+$45.91M(+2.96%)Summary
- As of today, PTGX TTM SG&A is -$1.51 billion, with the most recent change of +$45.91 million (+2.96%) on September 30, 2025.
- Over the past year, PTGX TTM SG&A has dropped by -$1.55 billion (-3638.38%).
- PTGX TTM SG&A is now -5392.90% below its all-time high of -$27.42 million.
Performance
PTGX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
PTGX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +29.8% | +9.6% | -3638.4% |
| 3Y3 Years | +59.8% | +61.3% | -4752.7% |
| 5Y5 Years | +176.0% | +127.6% | -8583.7% |
PTGX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +59.8% | -25.4% | +67.8% | at high | +38.2% |
| 5Y | 5-Year | at high | +176.0% | -25.4% | +127.6% | -54.1% | +38.2% |
| All-Time | All-Time | at high | +2236.7% | -25.4% | +2099.6% | -5392.9% | +38.2% |
PTGX Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $11.13M(+5.5%) | $42.37M(+2.3%) |
| Jun 2025 | - | $10.55M(-10.1%) | $41.40M(+2.8%) |
| Mar 2025 | - | $11.74M(+31.1%) | $40.29M(-7.3%) |
| Dec 2024 | $43.46M(+29.8%) | $8.95M(-11.9%) | $43.46M(+2.1%) |
| Sep 2024 | - | $10.16M(+7.6%) | $42.56M(+6.2%) |
| Jun 2024 | - | $9.44M(-36.7%) | $40.06M(+0.7%) |
| Mar 2024 | - | $14.91M(+85.2%) | $39.80M(+18.8%) |
| Dec 2023 | $33.49M(+5.5%) | $8.05M(+5.1%) | $33.49M(+4.4%) |
| Sep 2023 | - | $7.66M(-16.5%) | $32.07M(+2.4%) |
| Jun 2023 | - | $9.17M(+6.6%) | $31.31M(+5.0%) |
| Mar 2023 | - | $8.61M(+29.7%) | $29.83M(-6.0%) |
| Dec 2022 | $31.74M(+16.7%) | $6.63M(-3.9%) | $31.74M(-1.9%) |
| Sep 2022 | - | $6.90M(-10.3%) | $32.37M(-1.1%) |
| Jun 2022 | - | $7.69M(-26.9%) | $32.72M(+3.1%) |
| Mar 2022 | - | $10.52M(+44.8%) | $31.75M(+16.7%) |
| Dec 2021 | $27.20M(+45.9%) | $7.26M(+0.1%) | $27.20M(+9.1%) |
| Sep 2021 | - | $7.26M(+8.1%) | $24.93M(+10.5%) |
| Jun 2021 | - | $6.71M(+12.6%) | $22.57M(+12.7%) |
| Mar 2021 | - | $5.96M(+19.4%) | $20.03M(+7.5%) |
| Dec 2020 | $18.64M | $4.99M(+2.1%) | $18.64M(+5.0%) |
| Sep 2020 | - | $4.89M(+17.1%) | $17.75M(+5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $4.18M(-8.7%) | $16.88M(+1.9%) |
| Mar 2020 | - | $4.58M(+11.4%) | $16.56M(+5.2%) |
| Dec 2019 | $15.75M(+15.0%) | $4.11M(+2.3%) | $15.75M(+3.9%) |
| Sep 2019 | - | $4.01M(+3.9%) | $15.16M(+4.5%) |
| Jun 2019 | - | $3.86M(+2.6%) | $14.51M(+5.0%) |
| Mar 2019 | - | $3.76M(+7.0%) | $13.82M(+0.9%) |
| Dec 2018 | $13.70M(+16.3%) | $3.52M(+4.6%) | $13.70M(+3.4%) |
| Sep 2018 | - | $3.36M(+5.8%) | $13.25M(+6.2%) |
| Jun 2018 | - | $3.18M(-12.7%) | $12.48M(+0.4%) |
| Mar 2018 | - | $3.64M(+18.6%) | $12.43M(+5.5%) |
| Dec 2017 | $11.78M(+69.2%) | $3.07M(+18.4%) | $11.78M(+4.4%) |
| Sep 2017 | - | $2.59M(-17.0%) | $11.28M(+9.9%) |
| Jun 2017 | - | $3.12M(+4.4%) | $10.27M(+20.3%) |
| Mar 2017 | - | $2.99M(+16.2%) | $8.54M(+22.6%) |
| Dec 2016 | $6.96M(+134.9%) | $2.57M(+63.2%) | $6.96M(+58.7%) |
| Sep 2016 | - | $1.58M(+13.0%) | $4.39M(+56.1%) |
| Jun 2016 | - | $1.40M(-1.4%) | $2.81M(+98.6%) |
| Mar 2016 | - | $1.42M(+179.6%) | $1.42M(+179.6%) |
| Dec 2015 | $2.96M(+59.3%) | - | - |
| Mar 2015 | - | $506.00K | $506.00K |
| Dec 2014 | $1.86M | - | - |
FAQ
- What is Protagonist Therapeutics, Inc. annual SG&A?
- What is the all-time high annual SG&A for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual SG&A year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly SG&A year-on-year change?
- What is Protagonist Therapeutics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. TTM SG&A year-on-year change?
What is Protagonist Therapeutics, Inc. annual SG&A?
The current annual SG&A of PTGX is $43.46M
What is the all-time high annual SG&A for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual SG&A is $43.46M
What is Protagonist Therapeutics, Inc. annual SG&A year-on-year change?
Over the past year, PTGX annual SG&A has changed by +$9.97M (+29.77%)
What is Protagonist Therapeutics, Inc. quarterly SG&A?
The current quarterly SG&A of PTGX is $11.13M
What is the all-time high quarterly SG&A for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly SG&A is $14.91M
What is Protagonist Therapeutics, Inc. quarterly SG&A year-on-year change?
Over the past year, PTGX quarterly SG&A has changed by +$972.00K (+9.57%)
What is Protagonist Therapeutics, Inc. TTM SG&A?
The current TTM SG&A of PTGX is -$1.51B
What is the all-time high TTM SG&A for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high TTM SG&A is -$27.42M
What is Protagonist Therapeutics, Inc. TTM SG&A year-on-year change?
Over the past year, PTGX TTM SG&A has changed by -$1.55B (-3638.38%)